Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review

BACKGROUND/AIMS: Membranous nephropathy (MN) is a major cause of nephrotic syndrome in adults. This study aimed to evaluate the effect of rituximab (RTX) in patients with idiopathic MN (iMN) who have a high risk of progression. METHODS: We retrospectively analyzed data of 13 patients with iMN, who r...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Soo-Jee, Kim, Ji-Hye, Noh, Hee-Won, Lee, Ga-Young, Lim, Jeong-Hoon, Jung, Hee-Yeon, Cho, Jang-Hee, Choi, Ji-Young, Kim, Chan-Duck, Kim, Yong-Lim, Park, Sun-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271724/
https://www.ncbi.nlm.nih.gov/pubmed/35421909
http://dx.doi.org/10.3904/kjim.2021.155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271724/
https://www.ncbi.nlm.nih.gov/pubmed/35421909
http://dx.doi.org/10.3904/kjim.2021.155

Ejemplares similares